H
Hui Xia
Researcher at Chinese Center for Disease Control and Prevention
Publications - 67
Citations - 1357
Hui Xia is an academic researcher from Chinese Center for Disease Control and Prevention. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 14, co-authored 33 publications receiving 1082 citations.
Papers
More filters
Journal ArticleDOI
National Survey of Drug-Resistant Tuberculosis in China
Yanlin Zhao,Shaofa Xu,Lixia Wang,Daniel P. Chin,Shengfen Wang,Guanglu Jiang,Hui Xia,Yang Zhou,Qiang Li,Xichao Ou,Yu Pang,Yuanyuan Song,Bing Zhao,Hongtao Zhang,Guangxue He,Jing Guo,Yu Wang +16 more
TL;DR: China has a serious epidemic of drug-resistant tuberculosis, linked to inadequate treatment in both the public health system and the hospital system, especially tuberculosis hospitals; however, primary transmission accounts for most cases.
Journal ArticleDOI
Spoligotyping and Drug Resistance Analysis of Mycobacterium tuberculosis Strains from National Survey in China
Yu Pang,Yang Zhou,Bing Zhao,Guan Liu,Guanglu Jiang,Hui Xia,Yuanyuan Song,Yuanyuan Shang,Shengfen Wang,Yanlin Zhao +9 more
TL;DR: Beijing family genotypes were still the predominant genotype throughout China, which exhibited a greater correlation with rifampin-resistance, ofloxacin-Resistance and MDR phenotypes than other TB spoligotypes, and some regions of China showed several unique characters in the distribution of M. tuberculosis genotypes.
Journal ArticleDOI
Clinically prevalent mutations in Mycobacterium tuberculosis alter propionate metabolism and mediate multidrug tolerance
Nathan D. Hicks,Jian Yang,Xiaobing Zhang,Bing Zhao,Yonatan H. Grad,Yonatan H. Grad,Liguo Liu,Xichao Ou,Zhili Chang,Hui Xia,Yang Zhou,Shengfen Wang,Jie Dong,Lilian Sun,Yafang Zhu,Yanlin Zhao,Qi Jin,Sarah M. Fortune,Sarah M. Fortune +18 more
TL;DR: A genome-wide association study of Mycobacterium tuberculosis clinical isolates finds mutations in prpR that alter propionate metabolism and mediate multidrug tolerance, defining a previously unrecognized and clinically prevalent class of M. tuberculosis variants that undermine antibiotic efficacy and drive drug resistance.
Journal ArticleDOI
Prevalence of tuberculosis drug resistance in 10 provinces of China.
Guang Xue He,Yanlin Zhao,Guang Lu Jiang,Yu Hong Liu,Hui Xia,Sheng Fen Wang,Li Xia Wang,Martien W. Borgdorff,Marieke J. van der Werf,Susan van den Hof +9 more
TL;DR: Programmatic management of drug-resistant TB, including high quality DST for patients at high risk of resistance and treatment with second-line drugs, should become the standard, especially in high MDR-TB settings.
Journal ArticleDOI
Diagnostic accuracy of the PURE-LAMP test for pulmonary tuberculosis at the county-level laboratory in China.
Xichao Ou,Qiang Li,Hui Xia,Yu Pang,Shengfen Wang,Bing Zhao,Yuanyuan Song,Yang Zhou,Yang Zheng,Zhijian Zhang,Zhiying Zhang,Junchen Li,Haiyan Dong,Jack Zhang,Kai Man Kam,Junying Chi,Shitong Huan,Daniel P. Chin,Yanlin Zhao +18 more
TL;DR: The study suggested that, in peripheral-level TB laboratories in China, the PURE-LAMP test showed high sensitivity and specificity for TB detection in TB suspects, making it a more effective, rapid, and safe method worthy of broader use in the future.